Inhibikase Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Inhibikase Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Inhibikase Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 8.88M shares, a 66.3% increase year-over-year.
  • Inhibikase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.33M shares, a 26.3% increase from 2022.
  • Inhibikase Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.22M shares, a 76.8% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 5.33M +1.11M +26.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 4.22M -14M -76.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 18.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.